Alzheimer's drug sharply criticized by medical experts

Aricept 23 mg, found to be ineffective and cause stomach upset, was devised to serve commercial aims and was approved despite a poor showing in company-sponsored tests, two medical investigators say. Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food and Drug Administration will do little to help most patients and bring misery to some, say two medical investigators.

Read the whole article on LA Times - Science

More from LA Times - Science